Completed PHASE4 INTERVENTIONAL 2-arm NCT06310642

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness (PAMS)

A Prospective Single-Blinded Randomized Field-Based Trial to Evaluate the Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

Sponsor: CHRISTUS Health

Conditions AMS Acute Mountain Sickness

Interventions Diphenhydramine Immediate descent from altitude. Prochlorperazine 10 mg

Updated 4 times since 2024 Last updated: May 24, 2024 Started: May 20, 2021 Primary completion: Mar 13, 2023 Completion: Mar 13, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on AMS and Acute Mountain Sickness, this trial is completed. The trial is conducted by CHRISTUS Health and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2024 — Jul 2024 [monthly]

Completed PHASE4
Apr 2024 — Jun 2024 [monthly]

Completed PHASE4

First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHRISTUS Health

Data source: CHRISTUS Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Corpus Christi, United States